BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Compaci G, Conte C, Oberic L, Ysebaert L, Laurent G, Despas F. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey. BMC Cancer 2019;19:1178. [PMID: 31795958 DOI: 10.1186/s12885-019-6337-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Compaci G, Laurent G. L’infirmière au cœur du dispositif d’assistance des malades ambulatoires dans l’après-cancer. La Revue de l'Infirmière 2022;71:27-28. [DOI: 10.1016/j.revinf.2022.03.010] [Reference Citation Analysis]
2 de Germay S, Berdaï D, Noize P. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives. Therapies 2022;77:229-240. [DOI: 10.1016/j.therap.2021.08.001] [Reference Citation Analysis]
3 Mancuso S, Scaturro D, Santoro M, Di Gaetano G, Vitagliani F, Falco V, Siragusa S, Gonnelli S, Mauro GL. Bone damage after chemotherapy for lymphoma: a real-world experience. BMC Musculoskelet Disord 2021;22:1024. [PMID: 34876084 DOI: 10.1186/s12891-021-04904-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lindberg Å, Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbaek K, Geisler CH, Jerkeman M. Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience. Hematol Oncol 2021. [PMID: 34713465 DOI: 10.1002/hon.2940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]